RPGR gene therapy presents challenges in cloning the coding sequence
<p><strong>Introduction:</strong> Currently, there are three Phase I/II clinical trials based on gene therapy ongoing to test different AAV.RPGR or deleted RPGR vectors on patients affected by X-linked retinitis pigmentosa. These three vectors differ in the adeno-associated viral (...
Huvudupphovsmän: | Martinez-Fernandez De La Camara, C, Cehajic-Kapetanovic, J, MacLaren, RE |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Taylor and Francis
2019
|
Liknande verk
Liknande verk
-
Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review
av: Buckley, TMW, et al.
Publicerad: (2021) -
Characterizing visual fields in RPGR related retinitis pigmentosa using octopus static-automated perimetry
av: Buckley, TMW, et al.
Publicerad: (2022) -
Association of a novel intronic variant in RPGR with hypomorphic phenotype of x-linked retinitis pigmentosa
av: Cehajic-Kapetanovic, J, et al.
Publicerad: (2020) -
Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
av: Taylor, LJ, et al.
Publicerad: (2023) -
Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
av: Wood, LJ, et al.
Publicerad: (2021)